








A Hospital-University Federation (FHU) is a center of excellence that brings together hospital teams, universities and research units around a leading-edge medical or scientific theme, in close collaboration with national research organizations and industrial partners.
FHUs are a key pillar of AP-HP’s strategy for research, education and innovation, developed in partnership with Inserm and Universities.
Context and Challenges
In an increasingly competitive international environment, marked by the emergence of new health, technological and societal challenges, strengthening translational and clinical research is essential.
The creation of Hospital-University Federations by AP-HP, Inserm and universities aims to strengthen links between hospitals, universities and research units, structure ecosystems of excellence and accelerate the transfer of innovation for the direct benefit of patients.
Objectives of the FHU, spearheads of AP-HP
FHUs aim to promote ambitious collaborative projects bringing together hospitals, universities, research units and institutional and industrial partners.
For the 2025–2030 period, 26 Hospital-University Federations have been accredited for a five-year term.
All University Hospital Federations (FHU) : 26 FHUs in total

Coordinator

Project Manager
Location
Website
Keywords
FHU CARE2

Cancer and Autoimmune / Inflammatory diseases Relationships – 2
Hôpital Bicêtre AP-HP, Université Paris-Saclay, Inserm U1184, Gustave Roussy
Cancer I Autoimmune diseases I T cell engager bispecific antibodies I CAR-T cells I Immune Checkpoints ICI
FHU BREATH

Bridging Research Efforts Against The Hush of Dyspnea
Hôpital de la Pitié Salpêtrière AP-HP, Sorbonne Université, Inserm UMR-S 1158
Dyspnoea suffering I Invisible suffering I Interdisciplinarity I Collaboration – Innovation
FHU COMET

Complement expertise and Therapeutics : from prototypical diseases to public health Issues
Hôpital Européen Georges-Pompidou AP-HP, U1138 Université Paris Cité – Inserm
Coming soon
Coming soon
FHU COURNAND

Transforming Pulmonary Vascular Medicine (André Cournand : prix Nobel de physiologie ou médecine en 1956)
Hôpital Bicêtre AP-HP, Université Paris Saclay, Inserm U999
Dyspnoea suffering I Invisible suffering I Interdisciplinarity I Collaboration I Innovation
FHU FOR LIFE

FédératiOn de Recherche pour la mise en Lumière par l’Imagerie du fœtus
Hôpital Necker-Enfants malades, AP-HP, LUMIERE, URP 7328 FETUS, Université Paris Cité
Fœtus | IRM | Diagnostic prénatal | Cœur fœtal | Cerveau fœtal | Placenta | Chirurgie fœtale in utero | Data
FHU FRAME

Finding Answers to Manage Endometriosis
Hôpital Cochin AP-HP, U1016 Université Paris Cité – Inserm
Coming soon
Endometriosis I Adenomyosis I Pain I Fertility
FHU GIFT

GroupE–Île-de-France Transplantation
Néphro/Tx rénale HSL (UPC) – Hépatol. Pitié‑Salp. AP‑HP/SU – Pneumo H. Marie‑Lannelongue GHSJ (UPSaclay)
Coming soon
Transplantation I Regeneration, Immunosuppression I Transversality
FHU GLIMMER

Gut, Liver and Microbiome Research
Hôpital Saint-Antoine AP-HP, Sorbonne Université, Inserm U938, CRSA
IBD I Microbiome I Liver I Cancer I Nutrition
FHU IMPEC

IMProving Emergency Care
Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne Université, UMRS 1166
Emergency I Research Care
FHU INDIRA

Improving Survival in Immunocompromised Patients with of Acute Respiratory Failure
Hôpital Saint-Louis AP-HP, U1342 Université Paris Cité – Inserm
Intensive care I respiratory distress I immunocompromised patients
FHU INFIRE

INnovation Fibrosis Inflammation REmodeling
Hôpital Bichat AP-HP, Université Paris Cité, Inserm U1149 Université Paris Cité – Inserm
Fibrosis I Inflammation I Tissue remodeling
FHU INFLAMME

Deciphering and treating undefined inflammation by precision medicine
Hôpital Tenon AP-HP, Sorbonne Université, Inserm U1155
https://www.fhu-inflamme.fr
Inflammation I Genomics I Precision diagnostics
FHU MAMUTH

Musculoskeletal Diseases and Therapeutic Innovations
Hôpital Trousseau AP‑HP, Sorbonne Université, Inserm U974
Neuromuscular Diseases I Musculoskeletal Diseases I Spinal Diseases, Innovative Therapies I Biotherapies
FHU MOSAIC²

Multiscale Optimized Strategy for Artificial Intelligence-based Imaging Biomarkers in Cancers
Hôpital Beaujon AP-HP, U1149 Université Paris Cité – Inserm
Imagomics I AI I Cancer
FHU NeuroVasc 2030

Removing technological, regulatory and safety barriers to the use of innovative digital approaches to significantly improve stroke care and research
Hôpital Lariboisière AP-HP, U1141 Université Paris Cité – Inserm
Stroke, Artificial Intelligence, Innovation
FHU Prem’IMPACT

PREMaturity and its consequences: IMproving Prevention And Care Through innovation
Hôpital Cochin AP-HP, U1153, U1141 Université Paris Cité – Inserm
Prematurity I Perinatal inflammation I Complicated Pregnancies
FHU PREVENT-HT

Predict and prevent heart failure in young subjects
Hôpital Cochin AP-HP, Université Paris Cité U970, laboratoire associé Imagine Paris Cardiomyopathy Center
Heart Failure I Genomics I Cardiomyopathy
FHU PROTHEE-2

PROsTHEtic joint infections (PJI): integrative study of immunoresponse, dynamics of bone loss and microbiological Environment in a challenging infection to develop innovative strategies of PReventiOn, THErapy and resEarch
Hôpital Lariboisière AP-HP, Service de Maladies Infectieuses et Tropicales
Prosthesis I infection I Bone
FHU RedGene

Gene Therapy in Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Hôpital Henri-Mondor AP-HP, Université Paris Est Créteil Val de Marne, Inserm U955
Sickle Cell Disease I Thalassemia I Gene Therapy
FHU S2C-HOPE

Safety and Security of Care in Hematology and Oncology Programs of Excellence
Hôpital Saint-Antoine AP-HP, Sorbonne Université, Inserm U938
Safety I Prevention I Cancer I Toxicities
FHU SENCODE

Targeting cellular senescence to repair the regeneration process in age-related diseases
Hôpital Henri‑Mondor, AP‑HP, Université Paris‑Est Créteil , Inserm U955, CEA Saclay, Institut Joliot
Senescence, I Regeneration
FHU TRANSVIR

Innovative strategies to treat chronic viral infections after hematopoietic stem cell and solid organ transplantation
Hôpital Saint-Louis AP-HP, UMR 722/U944, Université Paris Cité
Transplantation I Virology I Immunotherapies
FHU Treat-FND

Improving Diagnosis, Treatment and Research in a frequent and overlooked disease: the Functional Neurological Disorders
Hôpital Avicenne AP-HP, Université Sorbonne Paris Nord, Inserm U1127
Coming soon
Functional neurological disorders I Treatment I Diagnosis, physiopathology
FHU TSUNAMI

Towards Strategies for Unmet Needs in Acute Mesenteric Ischemia
Hôpital Beaujon AP-HP, U1148 Université Paris Cité – Inserm
Mesenteric ischemia,I Biomarker, I Diagnosis
FHU UMANHYS

Upgrading the MANagement of chronic HYpoventilation through Sleep
Hôpital Pitié-Salpêtrière, Sorbonne Université, Inserm U1158, hôpital Raymond-Poincaré, Université Paris Saclay, Inserm U1179
Coming soon
Hypoventilation I Respiratory failure I Sleep
FHU VEAVE

Violence against children and adolescents and their lifelong consequences
Hôpital Necker-Enfants malades AP-HP, U1153 Université Paris Cité – Inserm
Child abuse and neglect I Epidemiology I Neuroscience

